List of signals discussed at PRAC since September 2012
Submitted by Anonymous (not verified) on 30 June 2025 - 8:51
List of signals discussed at PRAC since September 2012
PRAC recommendations on signals adopted at the 2-5 June 2025 PRAC meeting
Submitted by Anonymous (not verified) on 30 June 2025 - 8:47
PRAC recommendations on signals adopted at the 2-5 June 2025 PRAC meeting
Requesting scientific advice or protocol assistance from EMA
Submitted by Anonymous (not verified) on 30 June 2025 - 8:23
Requesting scientific advice or protocol assistance from EMA
Human medicines European public assessment report (EPAR): Levetiracetam Actavis Group, levetiracetam, Date of authorisation: 04/12/2011, Revision: 19, Status: Authorised
Submitted by Anonymous (not verified) on 30 June 2025 - 8:08
Human medicines European public assessment report (EPAR): Levetiracetam Actavis Group, levetiracetam, Date of authorisation: 04/12/2011, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of authorisation: 23/04/2025, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 30 June 2025 - 7:27
Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of authorisation: 23/04/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 30 June 2025 - 6:20
Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 7, Status: Authorised
Annual activity report 2024
Submitted by Anonymous (not verified) on 27 June 2025 - 16:52
Annual activity report 2024
Human medicines European public assessment report (EPAR): Xelevia, sitagliptin, Date of authorisation: 21/03/2007, Revision: 41, Status: Authorised
Submitted by Anonymous (not verified) on 27 June 2025 - 15:27
Human medicines European public assessment report (EPAR): Xelevia, sitagliptin, Date of authorisation: 21/03/2007, Revision: 41, Status: Authorised
Human medicines European public assessment report (EPAR): Tesavel, sitagliptin, Date of authorisation: 10/01/2008, Revision: 28, Status: Authorised
Submitted by Anonymous (not verified) on 27 June 2025 - 15:26
Human medicines European public assessment report (EPAR): Tesavel, sitagliptin, Date of authorisation: 10/01/2008, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Ristaben, sitagliptin, Date of authorisation: 15/03/2010, Revision: 29, Status: Authorised
Submitted by Anonymous (not verified) on 27 June 2025 - 15:25
Human medicines European public assessment report (EPAR): Ristaben, sitagliptin, Date of authorisation: 15/03/2010, Revision: 29, Status: Authorised